SCD2 Antibodies

Santa Cruz Biotechnology provides a broad selection of SCD2 monoclonal antibodies for various research applications. SCD2 Antibodies are optimized for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Stearoyl-CoA desaturase 2 (SCD2) plays a crucial role in lipid metabolism by catalyzing the conversion of saturated fatty acids to monounsaturated fatty acids, which is essential for maintaining cellular membrane integrity and function. SCD2 is extensively involved in various metabolic processes and has been linked to conditions such as obesity and insulin resistance, making it a significant target for research in metabolic diseases. Understanding the function and regulation of SCD2 can provide insights into therapeutic strategies for metabolic conditions. Researchers worldwide utilize SCD2 monoclonal antibodies to investigate lipid metabolism pathways and their impact on cellular function. Advanced detection methods, including fluorescein isothiocyanate (FITC) and horseradish peroxidase (HRP) conjugates, enable precise visualization of SCD2 in experimental settings. Santa Cruz Biotechnology monoclonal antibodies support the scientific community by facilitating breakthrough discoveries in metabolic disease research.